Newly diagnosed with
Type 1 Diabetes?

See if a new research study at
Joslin Diabetes Center is right for you.

About the Study

If you’re 16 years or older and were diagnosed with type 1 diabetes within the past 12 months, you may qualify for a new clinical study at Joslin Diabetes Center in Boston.

Type 1 diabetes is a serious condition in which the pancreas stop producing insulin - a hormone that helps the body to get energy from food. This happens when the body’s own immune system mistakenly destroys insulin-producing cells in the pancreas.

Doctors at Joslin Diabetes Center in Boston are evaluating AVT001, an investigational cellular vaccine for type 1 diabetes. The AVT001 vaccine is made from a person’s own cells and is injected into the arm. Researchers believe the AVT001 vaccine may help correct the root cause of type 1 diabetes, thus preserving the body’s ability to produce insulin.

If you qualify and choose to join the study, you will receive all study-related care at no cost from a specialist at Joslin Diabetes Center.

Why Participate?

Doctors at Joslin Diabetes Center are evaluating an investigational cellular vaccine for diabetes, called AVT001. If you are 16 years or older and were diagnosed with type 1 diabetes within the past 12 months, you may be eligible to participate. If you qualify and choose to join the study you will receive:

  • Evaluations of your type 1 diabetes from a specialist at Joslin Diabetes Center
  • All study-related care at no cost
  • Compensation for your time and travel to attend study visits
  • The opportunity to help advance type 1 diabetes research to possibly benefit others with type 1 diabetes

 

Are You Eligible?

To see if you might qualify for the study, and to get connected with a research specialist at Joslin Diabetes Center to discuss the study further, please complete the questionnaire below.